These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 37471227)

  • 1. Structural definition of HLA class II-presented SARS-CoV-2 epitopes reveals a mechanism to escape pre-existing CD4
    Chen Y; Mason GH; Scourfield DO; Greenshields-Watson A; Haigh TA; Sewell AK; Long HM; Gallimore AM; Rizkallah P; MacLachlan BJ; Godkin A
    Cell Rep; 2023 Aug; 42(8):112827. PubMed ID: 37471227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD8
    Qiu C; Xiao C; Wang Z; Zhu G; Mao L; Chen X; Gao L; Deng J; Su J; Su H; Fang EF; Zhang ZJ; Zhang J; Xie C; Yuan J; Luo OJ; Huang LA; Wang P; Chen G
    Front Immunol; 2021; 12():764949. PubMed ID: 35116022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breadth and Durability of SARS-CoV-2-Specific T Cell Responses following Long-Term Recovery from COVID-19.
    Dang TTT; Anzurez A; Nakayama-Hosoya K; Miki S; Yamashita K; de Souza M; Matano T; Kawana-Tachikawa A
    Microbiol Spectr; 2023 Aug; 11(4):e0214323. PubMed ID: 37428088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening HLA-A-restricted T cell epitopes of SARS-CoV-2 and the induction of CD8
    Jin X; Ding Y; Sun S; Wang X; Zhou Z; Liu X; Li M; Chen X; Shen A; Wu Y; Liu B; Zhang J; Li J; Yang Y; Qiu H; Shen C; He Y; Zhao G
    Cell Mol Immunol; 2021 Dec; 18(12):2588-2608. PubMed ID: 34728796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The HLA-II immunopeptidome of SARS-CoV-2.
    Weingarten-Gabbay S; Chen DY; Sarkizova S; Taylor HB; Gentili M; Hernandez GM; Pearlman LR; Bauer MR; Rice CM; Clauser KR; Hacohen N; Carr SA; Abelin JG; Saeed M; Sabeti PC
    Cell Rep; 2024 Jan; 43(1):113596. PubMed ID: 38117652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 coronavirus vaccine T cell epitope prediction analysis based on distributions of HLA class I loci (HLA-A, -B, -C) across global populations.
    Cun Y; Li C; Shi L; Sun M; Dai S; Sun L; Shi L; Yao Y
    Hum Vaccin Immunother; 2021 Apr; 17(4):1097-1108. PubMed ID: 33175614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimal Crossover between Mutations Associated with Omicron Variant of SARS-CoV-2 and CD8
    Redd AD; Nardin A; Kared H; Bloch EM; Abel B; Pekosz A; Laeyendecker O; Fehlings M; Quinn TC; Tobian AAR
    mBio; 2022 Apr; 13(2):e0361721. PubMed ID: 35229637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 specific memory T cell epitopes identified in COVID-19-recovered subjects.
    Zhao J; Wang L; Schank M; Dang X; Lu Z; Cao D; Khanal S; Nguyen LN; Nguyen LNT; Zhang J; Zhang Y; Adkins JL; Baird EM; Wu XY; Ning S; Gazzar ME; Moorman JP; Yao ZQ
    Virus Res; 2021 Oct; 304():198508. PubMed ID: 34329696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoinformatics prediction of overlapping CD8
    Fatoba AJ; Maharaj L; Adeleke VT; Okpeku M; Adeniyi AA; Adeleke MA
    Vaccine; 2021 Feb; 39(7):1111-1121. PubMed ID: 33478794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenic T cell epitopes of SARS-CoV-2 are recognized by circulating memory and naïve CD8 T cells of unexposed individuals.
    Quiros-Fernandez I; Poorebrahim M; Fakhr E; Cid-Arregui A
    EBioMedicine; 2021 Oct; 72():103610. PubMed ID: 34627082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Broadly recognized, cross-reactive SARS-CoV-2 CD4 T cell epitopes are highly conserved across human coronaviruses and presented by common HLA alleles.
    Becerra-Artiles A; Calvo-Calle JM; Co MD; Nanaware PP; Cruz J; Weaver GC; Lu L; Forconi C; Finberg RW; Moormann AM; Stern LJ
    Cell Rep; 2022 Jun; 39(11):110952. PubMed ID: 35675811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surveillance of SARS-CoV-2 immunogenicity: loss of immunodominant HLA-A*02-restricted epitopes that activate CD8
    Lopes-Ribeiro Á; Oliveira PM; Retes HM; Barbosa-Stancioli EF; da Fonseca FG; Tsuji M; Coelho-Dos-Reis JGA
    Front Immunol; 2023; 14():1229712. PubMed ID: 38022506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico analysis of mutant epitopes in new SARS-CoV-2 lineages suggest global enhanced CD8+ T cell reactivity and also signs of immune response escape.
    Pretti MAM; Galvani RG; Scherer NM; Farias AS; Boroni M
    Infect Genet Evol; 2022 Apr; 99():105236. PubMed ID: 35149224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2-specific CD8
    Rowntree LC; Petersen J; Juno JA; Chaurasia P; Wragg K; Koutsakos M; Hensen L; Wheatley AK; Kent SJ; Rossjohn J; Kedzierska K; Nguyen TH
    Immunol Cell Biol; 2021 Oct; 99(9):990-1000. PubMed ID: 34086357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of HLA-A2 restricted CD8
    Deng J; Pan J; Qiu M; Mao L; Wang Z; Zhu G; Gao L; Su J; Hu Y; Luo OJ; Chen G; Wang P
    J Leukoc Biol; 2021 Dec; 110(6):1171-1180. PubMed ID: 34231935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 Omicron BA.4/BA.5 Mutations in Spike Leading to T Cell Escape in Recently Vaccinated Individuals.
    Emmelot ME; Vos M; Boer MC; Rots NY; van Els CACM; Kaaijk P
    Viruses; 2022 Dec; 15(1):. PubMed ID: 36680141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large-Scale Identification of T-Cell Epitopes Derived From Severe Acute Respiratory Syndrome Coronavirus 2 for the Development of Peptide Vaccines Against Coronavirus Disease 2019.
    Ma Y; Liu F; Lin T; Chen L; Jiang A; Tian G; Nielsen M; Wang M
    J Infect Dis; 2021 Sep; 224(6):956-966. PubMed ID: 34145459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of SARS-CoV-2 Nucleocapsid and Spike T-Cell Epitopes for Assessing T-Cell Immunity.
    Lee E; Sandgren K; Duette G; Stylianou VV; Khanna R; Eden JS; Blyth E; Gottlieb D; Cunningham AL; Palmer S
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33443088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Basis of a Dominant SARS-CoV-2 Spike-Derived Epitope Presented by HLA-A*02:01 Recognised by a Public TCR.
    Szeto C; Nguyen AT; Lobos CA; Chatzileontiadou DSM; Jayasinghe D; Grant EJ; Riboldi-Tunnicliffe A; Smith C; Gras S
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 spike protein-derived immunogenic peptides that are promiscuously presented by several HLA-class II molecules and their potential for inducing acquired immunity.
    Yajima Y; Kosaka A; Ohkuri T; Hirohashi Y; Li D; Nagasaki T; Nagato T; Torigoe T; Kobayashi H
    Heliyon; 2023 Sep; 9(9):e20192. PubMed ID: 37809871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.